drugset / Trial / NCT01359579
A Study of the Pharmacokinetics and Safety of Varespladib in Subjects With Normal or Impaired Renal Function
Non-randomizedParallel-groupOpen-labelBasic science
Summary
The purpose of this study is to compare and evaluate the pharmacokinetic characteristics and the safety of varespladib methyl in mild or moderate renal impairment patients and healthy volunteers.
Timeline
- Start
- 2011-06
- Primary completion
- 2012-04
- Completion
- 2012-06
Outcome
Outcome not reported
Stopped: “Lack of efficacy”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Varespladib Methyl | Small molecule | 500 mg | Oral |